Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
The American Journal of Medicine|December 25, 2003
Hypercoagulability in sickle cell disease: a curious paradoxKenneth I Ataga, Eugene P Orringer
The Journal of Biological Chemistry|August 5, 2004
Mechanism of CD47-induced alpha4beta1 integrin activation and adhesion in sickle reticulocytesJulia E Brittain, Jaewon Han, Kenneth I Ataga, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 8, 2006
Biologically active CD40 ligand is elevated in sickle cell anemia: potential role for platelet-mediated inflammationSheritha P Lee, Kenneth I Ataga, Eugene P Orringer, et al.
British Journal of Haematology|April 22, 2008
Fibronectin bridges monocytes and reticulocytes via integrin alpha4beta1Julia E Brittain, Christine M Knoll, Kenneth I Ataga, et al.
Transfusion|February 6, 2008
Lack of Duffy antigen expression is associated with organ damage in patients with sickle cell diseaseAraba Afenyi-Annan, Melanie Kail, Martha R Combs, et al.
British Journal of Haematology|June 29, 2006
Pulmonary hypertension in patients with sickle cell disease: a longitudinal studyKenneth I Ataga, Charity G Moore, Susan Jones, et al.
Transfusion|December 3, 2014
Alloimmunization in sickle cell disease: changing antibody specificities and association with chronic pain and decreased survivalMarilyn J Telen, Araba Afenyi-Annan, Melanie E Garrett, et al.
British Journal of Haematology|October 6, 2007
Phase I study of eptifibatide in patients with sickle cell anaemiaSheritha P Lee, Kenneth I Ataga, Mohamed Zayed, et al.
Clinical and Translational Science|July 24, 2014
A model for developing, evaluating, and disseminating best practices in education and trainingMorris Weinberger, Susan N Pusek, Denise A Esserman, et al.
Pharmacotherapy|October 27, 2006
Dose-escalation study of ICA-17043 in patients with sickle cell diseaseKenneth I Ataga, Eugene P Orringer, Lori Styles, et al.
Pageof 3